Page 79 - OHKF_Biotech_2021_TC
P. 79

The HKSAR Government. (2021, March 24). GovHK: Offices Outside Hong Kong. Retrieved from https://www.gov.hk/en/about/govdirectory/oohk.htm
            The Hong Kong Mortgage Corporation Limited. (2021, April 30). SME Financing Guarantee Scheme. Retrieved from https://www.hkmc.com.hk/eng/our_
               business/sme_financing_guarantee_scheme.html
            The Hong Kong University of Science and Technology. (2017, June 30). Financial Statements. Retrieved from https://archives.ust.hk/dspace/
               bitstream/9999/45769/1/coun-03-a027.pdf
            The University of Hong Kong. (2019, September). University Overhead Charging Policy. Retrieved from https://www.feo.hku.hk/finance/information/
               overheadpolicy.html?v=

            The White House. (2012). National Bioeconomy Blueprint, April 2012. Industrial Biotechnology, 8(3). doi:10.1089/ind.2012.1524
            The White House. (2021, February 23). Office of Science and Technology Policy. Retrieved from https://www.whitehouse.gov/ostp/
            UGC. (n.d.). Retrieved from https://www.ugc.edu.hk/eng/ugc/index.html

            University of Cambridge. (2015, June 25). MPhil in Bioscience Enterprise. Retrieved from https://www.postgraduate.study.cam.ac.uk/courses/directory/
               egcempbse
            VOLAB (2016年)。深圳國家級重點實驗室已達14家。http://www.volab.com.cn/Article/shenguojiajizhongdia_1.html

            Weise, E., & Weintraub, K. (2021, February 08). A COVID-19 vaccine life cycle: From DNA to doses. Retrieved from https://www.usatoday.com/in-depth/
               news/health/2021/02/07/how-covid-vaccine-made-step-step-journey-pfizer-dose/4371693001/

            World Health Organization. (2010). Good Laboratory Practice training manual: For the trainer: A tool for training and promoting Good
              Laboratory Practice (GLP) concepts in disease endemic countries. Geneva: World Health Organization.
            World Health Organizaiton. (2012). WHO Expert Committee on Specifications for Pharmaceutical Preparations: Forty-sixth report. Geneva, Switzerland:
               World Health Organization.
            World Health Organization (2021, May 28). Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process. Retrieved from https://extranet.who.int/
               pqweb/sites/default/files/documents/Status_COVID_VAX_28May2021.pdf









                                                                                                                                      77
   74   75   76   77   78   79   80   81   82   83   84